Saidal Group is an Algerian pharmaceutical company created in 1982. Saidal Group is the largest pharmaceutical company in Algeria and one of the largest in Africa.
Saidal Group exports its products to Ivory Coast, Gabon, Senegal, Cameroon, Mali, Democratic Republic of the Congo, Republic of the Congo, Niger, Togo, Benin, Guinea-Bissau, Chad and Mauritania.[1]
History
Saidal was created in April 1982 following the restructuring of the Algerian Central Pharmacy. In 1985, it changed its name to become Saidal.
In 1989, Saidal became an economic public company, one of the first national company to acquire the status of joint stock company in 1993. In 1997, Saidal was transformed into an industrial group, which Biotic, Pharmal and Antibiotical were attached.[2]
In March 2022, the group announced the launch of its first bioequivalence center called "Equival".[3]
Company management
Saïdal is headed by :
- Ali Aoun (1995–2008)
- Rachid Zahouani (2008–?)
External links
References
- Le groupe Saidal exportera prochainement ses produits vers 13 pays africains www.huffpostmaghreb.com^
- Saidal : Un groupe aux grandes ambitions www.elmoudjahid.com^
- Saidal Group: Bioequivalence center opens in March Algeria Press Service, March 10, 2022, retrieved March 10, 2022^
- Mohamed Nouas, new CEO of Saidal group Algeria Press Service, January 3, 2018, retrieved January 3, 2018^
- Boudjedri Mounia. Mme Fatouma Akacem installée dans ses nouvelles fonctions de PDG de Saïdal Algeria Press Service, February 11, 2020, retrieved February 11, 2020^
- Wassim Kouidri, new CEO of SAIDAL Algeria Press Service, retrieved April 11, 2023^